Dalton Venture

Dalton Venture is a fund management company established in 2015 and based in Shanghai, China. It focuses on early-stage investments in the healthcare sector, particularly in medical services, biotechnology, and healthcare technology. Additionally, Dalton Venture engages in industrial mergers and acquisitions within the big health domain, aiming to foster innovation and growth in this critical field.

Ning Huang

Founding Partner

Qi Sun

Founding Management Partner

46 past transactions

Yuantian Bio

Seed Round in 2025
Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET applications. They have achieved low-cost fermentation preparation of over 10 enzyme preparations and large-scale biochemical product preparation.

Astribot

Series A in 2025
Astribot specializes in designing and developing AI-driven, humanoid robots capable of performing a wide range of household tasks autonomously. These robots, which include consumer humanoids and integrated bionics, are engineered to exhibit high dexterity, speed, and intelligence, offering customers innovative and reliable solutions.

Yuetong Eye Clinic

Series A in 2024
Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.

Xiwei Biotechnology

Series A in 2024
Xiwei Biotechnology is an ophthalmology implanted medical device developer that specializes in the unique product development of new bio-modified materials for ocular implantable medical devices and regenerative medicine.

Macrolux Medical

Series B in 2024
Macrolux Medical is a medical technology company that specializes in endoscopic interventional solutions. It focuses on developing devices for both diagnosis and treatment across various medical fields, including urology, respiratory, and digestive health. By promoting these innovative solutions to a wide range of medical customers, Macrolux aims to enhance patient outcomes through earlier detection and improved treatment options. The company's commitment to advancing endoscopic therapy positions it as a key player in the medical device sector.

PharMolix

Seed Round in 2024
PharMolix Inc. is an AI & Biotechnology company that aims to revolutionize the biomedical industry with multi-modal AI foundation models.

Mol Breeding

Series B in 2024
Molbreeding is a biotechnology company specializing in molecular breeding technology for both animals and plants. It offers advanced genotyping solutions aimed at enhancing breeding processes. The firm emphasizes research and development in this field, utilizing proprietary technologies such as GenoPlexs and GenoBaits. These innovations provide customers with high capture efficiency, extensive coverage, and adaptable sample options, all while maintaining cost-effective custom services. Molbreeding's focus on molecular breeding positions it as a key player in the advancement of agricultural biotechnology.

Aiyisheng

Angel Round in 2024
Aiyisheng is a food manufacturing business that focuses on the creation, development, manufacturing, and marketing of nutritious foods. Aiyisheng offers a range of health foods including vitamins, minerals, dietary supplements, and others. It provides consumers with healthy food products with its professional R&D capabilities.

Jichen Biotechnology

Seed Round in 2024
Jichen Biotechnology designs, manufactures, supplies, and maintains automation and information equipment systems.

Oushisheng Technology

Series B in 2024
Oushisheng Technology is a national high-tech company that provides complete solutions for micro-reaction flow chemistry to people all over the world.

Sino-Biocan

Series B in 2024
Zhongbo Ruikang focuses on the research and development of domestic tools in the field of cell and gene therapy, mainly to assist customers in realizing the "continuous, closed, disposable, consistent, scalable, automated, modular, and medical deviceization of cell preparation industrialization.

Macrolux Medical

Series A in 2024
Macrolux Medical is a medical technology company that specializes in endoscopic interventional solutions. It focuses on developing devices for both diagnosis and treatment across various medical fields, including urology, respiratory, and digestive health. By promoting these innovative solutions to a wide range of medical customers, Macrolux aims to enhance patient outcomes through earlier detection and improved treatment options. The company's commitment to advancing endoscopic therapy positions it as a key player in the medical device sector.

Bingjing Smart

Seed Round in 2024
Bingjing Smart is a cardiovascular interventional imaging company. It is an acoustics-based startup that uses imaging as a form of communication and is aiming for the digital medical revolution. It creates specialist digital interventional imaging products for heart and vascular illnesses. It helps in advancement of digital cardiovascular interventional imaging, leveraging digital to empower the entire process of cardiovascular disease diagnosis and treatment.

Rhino Medical

Series A in 2023
Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments

Jingqin Intelligent Manufacturing

Angel Round in 2023
Jingqin Intelligent Manufacturing is an innovative technology company that specializes in developing surgical instruments in the medical field.

HC Scientific

Series B in 2023
HC Scientific (Chengdu) L.L.C., established in 2016, is a national high-tech enterprise focused on developing intelligent solutions in life technology. The company aims to empower life sciences through innovative products, including genetic testing instruments, reagents, and software, primarily used in clinical molecular diagnostics, health gene testing, and agricultural molecular breeding. HC Scientific is committed to autonomous research and development of intellectual property and is recognized for its contributions to China's new economy development initiatives. The organization employs a team of experts, including returning PhDs and professors, who have developed advanced life science technology platforms. Through its diverse product pipeline, HC Scientific streamlines complex tasks for practitioners in the life science field, thereby creating substantial value for its partners and contributing to significant national and provincial scientific and technological projects.

FUE Bioscience

Series A in 2023
FUE Bioscience is a medical robot R&D business that specializes in microsurgery above the head and neck. It continues to develop a product matrix of fully intelligent, high-precision, and anthropomorphic surgical robots based on the platform of macro-micro-controlled humanoid dual-arm robots.

Mol Breeding

Series A in 2023
Molbreeding is a biotechnology company specializing in molecular breeding technology for both animals and plants. It offers advanced genotyping solutions aimed at enhancing breeding processes. The firm emphasizes research and development in this field, utilizing proprietary technologies such as GenoPlexs and GenoBaits. These innovations provide customers with high capture efficiency, extensive coverage, and adaptable sample options, all while maintaining cost-effective custom services. Molbreeding's focus on molecular breeding positions it as a key player in the advancement of agricultural biotechnology.

Bingjing Smart

Seed Round in 2023
Bingjing Smart is a cardiovascular interventional imaging company. It is an acoustics-based startup that uses imaging as a form of communication and is aiming for the digital medical revolution. It creates specialist digital interventional imaging products for heart and vascular illnesses. It helps in advancement of digital cardiovascular interventional imaging, leveraging digital to empower the entire process of cardiovascular disease diagnosis and treatment.

Shanhai Semiconductor

Series A in 2023
Shanhai Semiconductor is a high-performance digital-analog hybrid and signal chain chip developer.

Borch Biotech

Angel Round in 2023
Borch Biotech is committed to the R&D and scientific research transformation of biological tissue membranes and derivative medical devices.

Yisuo Intelligent

Angel Round in 2023
Yisuo Intelligent is a scientific research and production start-up company dedicated to new pharmaceutical packaging technology and intelligent drug delivery systems. Their products include pharmaceutical material precision devices, targeted drug delivery devices, and precision intelligent systems to serve the pharmaceutical industry.

Macrolux Medical

Series A in 2023
Macrolux Medical is a medical technology company that specializes in endoscopic interventional solutions. It focuses on developing devices for both diagnosis and treatment across various medical fields, including urology, respiratory, and digestive health. By promoting these innovative solutions to a wide range of medical customers, Macrolux aims to enhance patient outcomes through earlier detection and improved treatment options. The company's commitment to advancing endoscopic therapy positions it as a key player in the medical device sector.

NowYonMedical

Venture Round in 2023
NowYonMedical specializes in the production of medical device products. It also offers technical consulting, health management, and technology research in the field of life sciences.

Eartech

Seed Round in 2022
Eartech is a company dedicated to the development of intelligent audiometry and hearing aids. It focuses on creating advanced hearing testing systems and hearing aid technologies designed to assist individuals with hearing impairments. By utilizing innovative chip and voice recognition technology, Eartech enhances sound processing, classification, and clarity, enabling users to improve their hearing capability. The company is committed to promoting the rapid advancement of the hearing aid industry while providing essential rehabilitation services for those with hearing challenges.

Juventas

Series C in 2021
Juventas is a developer of innovative immune cell therapeutic drugs aimed at treating malignant hematological neoplasms, including leukemia and lymphoma. The company has had its first investigational new drug application for the cell therapeutic product CNCT19 accepted by the National Medical Products Administration. Juventas is committed to developing a comprehensive product pipeline that focuses on advancing immune cell therapies and accelerating innovation in this field, thereby providing effective treatment options for patients suffering from these serious conditions.

Triastek

Series B in 2021
Triastek Co. Ltd., established in 2015 and headquartered in Nanjing, China, specializes in the manufacturing of 3D printed pharmaceuticals and related medical equipment. The company offers a range of drugs, including blockbuster and orphan drugs, along with complex drug delivery technologies. Triastek's portfolio includes 3D drug printing services, such as formulation design, equipment, and development methods, with patents secured in key global markets like China, the US, Europe, and Japan. Notably, the company owns Melt Extrusion Deposition (MED), a universally applicable 3D printing technology for solid formulations. Triastek's mission is to revolutionize drug delivery, development, and manufacturing through its proprietary 3D printing technology.

Forerunner Medical

Series B in 2021
Forerunner Medical (Shanghai) Co., Ltd., established in 2009, specializes in the development and manufacturing of innovative medical devices aimed at minimally invasive treatments. The company focuses on creating low-temperature plasma radio-frequency generators and electrodes specifically designed for sports medicine and tumor treatment. By leveraging extensive domestic clinical data and advanced technology, Forerunner Medical aims to meet both domestic and global healthcare needs. The organization emphasizes the quality and safety of its products, ensuring high performance, aesthetic appeal, and user convenience. Its commitment to excellence is reflected in its state-of-the-art production equipment and professional expertise, which contribute to its competitive advantage in the medical device industry.

Triastek

Series A in 2020
Triastek Co. Ltd., established in 2015 and headquartered in Nanjing, China, specializes in the manufacturing of 3D printed pharmaceuticals and related medical equipment. The company offers a range of drugs, including blockbuster and orphan drugs, along with complex drug delivery technologies. Triastek's portfolio includes 3D drug printing services, such as formulation design, equipment, and development methods, with patents secured in key global markets like China, the US, Europe, and Japan. Notably, the company owns Melt Extrusion Deposition (MED), a universally applicable 3D printing technology for solid formulations. Triastek's mission is to revolutionize drug delivery, development, and manufacturing through its proprietary 3D printing technology.

Noah Healthcare

Series A in 2019
Noah Healthcare is a private clinic based in Guangzhou, China, specializing in healthcare services for women and children. The clinic focuses on pediatrics, obstetrics, and gynecology, offering a range of medical services that cater to children aged 0 to 18, including treatment for common diseases, health examinations, growth and development assessments, and vaccinations. Additionally, Noah Healthcare provides women with comprehensive services related to pregnancy preparation, pre-pregnancy examinations, maternal healthcare, post-natal conditioning, and screening for dysplasia. Notably, it was the first to establish a professional ultrasound center in Guangdong Province and employs a core team of renowned foreign experts in women's and children's health, ensuring that patients receive high-quality, internationally standardized medical care.

Juventas

Series A in 2019
Juventas is a developer of innovative immune cell therapeutic drugs aimed at treating malignant hematological neoplasms, including leukemia and lymphoma. The company has had its first investigational new drug application for the cell therapeutic product CNCT19 accepted by the National Medical Products Administration. Juventas is committed to developing a comprehensive product pipeline that focuses on advancing immune cell therapies and accelerating innovation in this field, thereby providing effective treatment options for patients suffering from these serious conditions.

Wellem

Series C in 2019
Wellem is an operator of pediatric clinic franchise. United Wellness Pediatric Gubei Clinic (Wellem) is a private clinic that provides care for babies, children, and young adults. They believe in leveraging competition and innovation to create better care, and base their service on the American service standard. They offer general pediatrics, pediatric dental care, specialized childcare, and imported vaccines. And can help children with any issue from physical growth, to nutrition, and language to vision, and even academic skills. Parents can also bring their children for preventative check ups, with little waiting time and simple registration.

NeighBor Doc

Series A in 2018
Neighbor Doc is an online platform that offers a range of healthcare services, aiming to transform community medical care by integrating general practice and specialty services. The organization focuses on providing convenient access to both online and offline medical consultations, covering various fields such as pediatrics, dental care, gynecology, and complex surgical procedures. With a commitment to affordability and quality, Neighbor Doc seeks to establish a comprehensive healthcare network that enhances the capabilities of community medical services, thereby ensuring that patients receive the necessary care in a timely and efficient manner.

Orange Dental

Series A in 2018
Orange Dental is a dental clinic that specializes in providing general dental care for children. The clinic is uniquely designed with a theme park decor to create a comforting environment, particularly for nervous young patients. This innovative approach aims to ensure a positive dental experience, allowing parents to select a more enjoyable and tailored service for their children. By combining effective dental care with a playful atmosphere, Orange Dental seeks to alleviate the anxiety often associated with dental visits for kids.

Wellem

Series B in 2018
Wellem is an operator of pediatric clinic franchise. United Wellness Pediatric Gubei Clinic (Wellem) is a private clinic that provides care for babies, children, and young adults. They believe in leveraging competition and innovation to create better care, and base their service on the American service standard. They offer general pediatrics, pediatric dental care, specialized childcare, and imported vaccines. And can help children with any issue from physical growth, to nutrition, and language to vision, and even academic skills. Parents can also bring their children for preventative check ups, with little waiting time and simple registration.

DeepWise

Series B in 2018
Beijing DeepWise Science And Technology Co., Ltd. is a company that specializes in developing artificial intelligence-based medical application software aimed at enhancing clinical imaging analysis and diagnostics. Founded in 2017 and located in Beijing, China, DeepWise focuses on early screening and diagnosis of various malignant diseases, including lung and breast cancers. Its AI-driven software improves efficiency and diagnostic accuracy in healthcare, offering solutions to hospitals, medical centers, and imaging centers. The company's technology supports the online reading and consultation of medical images, leveraging big data in the cloud to facilitate timely and accurate disease detection and treatment.

Orange Dental

Series A in 2018
Orange Dental is a dental clinic that specializes in providing general dental care for children. The clinic is uniquely designed with a theme park decor to create a comforting environment, particularly for nervous young patients. This innovative approach aims to ensure a positive dental experience, allowing parents to select a more enjoyable and tailored service for their children. By combining effective dental care with a playful atmosphere, Orange Dental seeks to alleviate the anxiety often associated with dental visits for kids.

DeepWise

Series A in 2017
Beijing DeepWise Science And Technology Co., Ltd. is a company that specializes in developing artificial intelligence-based medical application software aimed at enhancing clinical imaging analysis and diagnostics. Founded in 2017 and located in Beijing, China, DeepWise focuses on early screening and diagnosis of various malignant diseases, including lung and breast cancers. Its AI-driven software improves efficiency and diagnostic accuracy in healthcare, offering solutions to hospitals, medical centers, and imaging centers. The company's technology supports the online reading and consultation of medical images, leveraging big data in the cloud to facilitate timely and accurate disease detection and treatment.

Landing Medical High Technology

Series B in 2017
Landing Shares is an AI-driven med-tech firm that develops artificial intelligence cervical cancer screening diagnostic technology.

Wellem

Series A in 2017
Wellem is an operator of pediatric clinic franchise. United Wellness Pediatric Gubei Clinic (Wellem) is a private clinic that provides care for babies, children, and young adults. They believe in leveraging competition and innovation to create better care, and base their service on the American service standard. They offer general pediatrics, pediatric dental care, specialized childcare, and imported vaccines. And can help children with any issue from physical growth, to nutrition, and language to vision, and even academic skills. Parents can also bring their children for preventative check ups, with little waiting time and simple registration.

xinws.com

Series A in 2016
xinws.com provides heart monitoring services to help their users discover every abnormal heart rhythm. The users can also learn about their heart health anytime and anywhere. They also offer programmes to help their users lose weight scientifically, lower blood sugar, blood lipids, blood pressure, and uric acid to reduce taking drugs to protect their heart health.

Yishengzhan

Series A in 2015
Yishengzhan is an online medical education community for doctors based in China.

Baisi Bude Jie

Series B in 2015
Baisi Bude Jie is a short piece of video entertainment community service provider.

Yixue Jie

Series A in 2014
Yixue Jie is an app that offers medical information to medical workers. They provide information in these categories such as grassroots medical voice in the medical field, medical tumor channel, medical rheumatology and immunity channel, medical skin channel, medical cardiovascular channel, medical endocrinology channel, medical neurology channel, medical blood channel, medical pediatric channel, medical obstetrics and gynecology channel, medical respiratory channel, medical nephrology channel, digestive liver disease channel in medical circles, clinical pharmacy channel of the medical community, medical rare disease channel, medical cancer association, medical emergency and critical care channel, medical spirit channel, medical surgical channel, medical nursing channel, medical ophthalmology channel, medical infection channel, medical anesthesia channel, medical orthopedics channel, medical testing channel, medical image diagnosis and intervention channel, medical pathology channel, clinical decision assistant, a course in the medical field, and medical examination. It helps clinicians in clinical decision-making and professional advancement.

xinws.com

Angel Round in 2014
xinws.com provides heart monitoring services to help their users discover every abnormal heart rhythm. The users can also learn about their heart health anytime and anywhere. They also offer programmes to help their users lose weight scientifically, lower blood sugar, blood lipids, blood pressure, and uric acid to reduce taking drugs to protect their heart health.

Aiyisheng

Aiyisheng is a food manufacturing business that focuses on the creation, development, manufacturing, and marketing of nutritious foods. Aiyisheng offers a range of health foods including vitamins, minerals, dietary supplements, and others. It provides consumers with healthy food products with its professional R&D capabilities.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.